Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Sep 30:374:n2061.
doi: 10.1136/bmj.n2061.

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

Affiliations

A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance

Kathryn Skivington et al. BMJ. .

Abstract

The UK Medical Research Council’s widely used guidance for developing and evaluating complex interventions has been replaced by a new framework, commissioned jointly by the Medical Research Council and the National Institute for Health Research, which takes account of recent developments in theory and methods and the need to maximise the efficiency, use, and impact of research.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at http://www.icmje.org/coi_disclosure.pdf and declare: support from the NIHR, MRC, and the funders listed above for the submitted work; KS has project grant funding from the Scottish Government Chief Scientist Office; SAS is a former member of the NIHR Health Technology Assessment Clinical Evaluation and Trials Programme Panel (November 2016 - November 2020) and member of the Chief Scientist Office Health HIPS Committee (since 2018) and NIHR Policy Research Programme (since November 2019), and has project grant funding from the Economic and Social Research Council, MRC, and NIHR; LMo is a former member of the MRC-NIHR Methodology Research Programme Panel (2015-19) and MRC Population Health Sciences Group (2015-20); JB is a member of the NIHR Public Health Research Funding Committee (since May 2019), and a core member (since 2016) and vice chairperson (since 2018) of a public health advisory committee of the National Institute for Health and Care Excellence; JMB is a former member of the NIHR Clinical Trials Unit Standing Advisory Committee (2015-19); DPF is a former member of the NIHR Public Health Research programme research funding board (2015-2019), the MRC-NIHR Methodology Research Programme panel member (2014-2018), and is a panel member of the Research Excellence Framework 2021, subpanel 2 (public health, health services, and primary care; November 2020 - February 2022), and has grant funding from the European Commission, NIHR, MRC, Natural Environment Research Council, Prevent Breast Cancer, Breast Cancer Now, Greater Sport, Manchester University NHS Foundation Trust, Christie Hospital NHS Trust, and BXS GP; EM is a member of the NIHR Public Health Research funding board; MP has grant funding from the MRC, UK Prevention Research Partnership, and NIHR; JR-M is programme director and chairperson of the NIHR’s Health Services Delivery Research Programme (since 2014) and member of the NIHR Strategy Board (since 2014); MW received a salary as director of the NIHR PHR Programme (2014-20), has grant funding from NIHR, and is a former member of the MRC’s Population Health Sciences Strategic Committee (July 2014 to June 2020). There are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Fig 1
Fig 1
Framework for developing and evaluating complex interventions. Context=any feature of the circumstances in which an intervention is conceived, developed, evaluated, and implemented; programme theory=describes how an intervention is expected to lead to its effects and under what conditions—the programme theory should be tested and refined at all stages and used to guide the identification of uncertainties and research questions; stakeholders=those who are targeted by the intervention or policy, involved in its development or delivery, or more broadly those whose personal or professional interests are affected (that is, who have a stake in the topic)—this includes patients and members of the public as well as those linked in a professional capacity; uncertainties=identifying the key uncertainties that exist, given what is already known and what the programme theory, research team, and stakeholders identify as being most important to discover—these judgments inform the framing of research questions, which in turn govern the choice of research perspective; refinement=the process of fine tuning or making changes to the intervention once a preliminary version (prototype) has been developed; economic considerations=determining the comparative resource and outcome consequences of the interventions for those people and organisations affected

References

    1. Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M, Medical Research Council Guidance . Developing and evaluating complex interventions: the new Medical Research Council guidance. BMJ 2008;337:a1655. 10.1136/bmj.a1655. - DOI - PMC - PubMed
    1. Craig P, Dieppe P, Macintyre S, et al. . Developing and evaluating complex interventions: new guidance. Medical Research Council, 2006.
    1. Campbell M, Fitzpatrick R, Haines A, et al. . Framework for design and evaluation of complex interventions to improve health. BMJ 2000;321:694-6. 10.1136/bmj.321.7262.694. - DOI - PMC - PubMed
    1. O’Cathain A, Croot L, Duncan E, et al. . Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open 2019;9:e029954. 10.1136/bmjopen-2019-029954 - DOI - PMC - PubMed
    1. Craig P, Cooper C, Gunnell D, et al. . Using natural experiments to evaluate population health interventions: new Medical Research Council guidance. J Epidemiol Community Health 2012;66:1182-6. 10.1136/jech-2011-200375 - DOI - PMC - PubMed